clinion

Insights / Awards

Clinion Wins the ACDM 2025 Innovation Award

Clinion at ACDM 2025 prague

We are happy to announce that Clinion has been awarded the ACDM 2025 Innovation Awards for Excellence in the Management of Clinical Data, recognizing our AI-powered Clinical Data Review as a breakthrough in clinical trial technology.

The Innovation That Won Recognition

Clinion’s Clinical Data Review was designed to give Data Managers the autonomy they need to keep studies moving. With instant access to tailored listings, real-time visibility into inconsistencies, and the ability to act within the same environment, teams gain more confidence and control over their daily workflows. The result is a smoother review cycle and a more resilient data process.

Why Clinion Stands Out

Natural Language Querying for Instant Data Listings

Clinion’s AI enables Data Managers to generate structured trial data in seconds using plain-language prompts. This removes reliance on SQL programmers and drastically reduces delays in data review, empowering teams to work faster and more efficiently.

 

Integrated Query Management Within the EDC

With AI-driven query management, users can flag inconsistencies and raise queries directly within the EDC Platform. This streamlined workflow accelerates issue detection, enhances compliance, and improves overall data accuracy throughout the trial.

 

AI-Powered Compliance and Risk Detection

Clinion’s AI instantly identifies missing or inconsistent data, ensuring real-time adherence to CDISC, FDA, and GCP standards. By automating compliance checks, trials maintain integrity and regulatory readiness while accelerating approvals.

Quote by MANUJ VANGIPURAPU

The Clinion Advantage

Faster Study Setup

0 %

Faster Data Review

0 %

Faster query resolution

0 %

Why This Award Matters

This achievement highlights Clinion’s commitment to AI-driven automation in clinical trials. Our AI-powered solutions streamline data review, enhance accuracy, and optimize workflows, delivering measurable impact at every stage. The recognition underscores the transformative role of intelligent automation in modern clinical research and reaffirms Clinion’s leadership in pioneering AI innovation in data management.

Unlock the Future of Clinical Trials with Clinion.

Cut your trial costs by 35% and accelerate your time-to-market by 30%

Compliance

Fully Compliant with Global Standards

FDA,HIPAA and ISO Logos
ich ,gdpr ,eu compliant logos
Clinion’s adherence to global regulatory standards including FDA 21 CFR Part 11, HIPAA, ISO 9001:2015, ISO 27001:2013, ICH, GDPR, and EU Annex 11.